| Drug Name: | Semaglutide |
|---|
| Drug Class: | Glucagon-like peptide-1 receptor agonist |
|---|
| Mechanism of Action: | Stimulates insulin secretion, inhibits glucagon secretion, slows gastric emptying, and promotes satiety |
|---|
| Use: | - Type 2 diabetes mellitus
- Weight management in adults with obesity
|
|---|
| Side Effects: | - Nausea
- Vomiting
- Diarrhea
- Hypoglycemia (when used with insulin or sulfonylureas)
|
|---|
| Contraindications: | - Hypersensitivity to semaglutide or any component of the formulation
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple endocrine neoplasia syndrome type 2 (MEN 2)
|
|---|
| Specialty: | - Endocrinology
- Internal Medicine
|
|---|